Eyedaptic, Inc. helps improve the vision of those suffering from retinal disorders including AMD (age related macular degeneration) through the development of software driven smart glasses, leveraging the power of augmented reality (AR) technology. Eyedaptic’s technology is used in products sold by the company and products and services sold and offered by its commercial partners.

This page is intended to serve as notice under 35 U.S.C. § 287(a).

The following U.S. patents apply to Eyedaptic products, EYE2, EYE3, EYE4, EYE5 and EYE6.

US Patent Numbers: 10,872,472; 10,984,508; 11,043,036; 11,187,906; 11,282,284; 11,385,468; 11,521,360; 11,563,885; 11,676,352; 11,726,561; 11,756,168; 11,803,061; 11,935,204; 12,033,291; 12,132,984